Cargando…
A review of Phase I trials of Ebola virus vaccines: what can we learn from the race to develop novel vaccines?
Sporadic outbreaks of Ebola virus infection have been documented since the mid-Seventies and viral exposure can lead to lethal haemorrhagic fever with case fatalities as high as 90%. There is now a comprehensive body of data from both ongoing and completed clinical trials assessing various vaccine s...
Autores principales: | Lambe, Teresa, Bowyer, Georgina, Ewer, Katie J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5394635/ https://www.ncbi.nlm.nih.gov/pubmed/28396468 http://dx.doi.org/10.1098/rstb.2016.0295 |
Ejemplares similares
-
Detection of Vaccine-Induced Antibodies to Ebola Virus in Oral Fluid
por: Lambe, Teresa, et al.
Publicado: (2016) -
Reduced Ebola vaccine responses in CMV(+) young adults is associated with expansion of CD57(+)KLRG1(+) T cells
por: Bowyer, Georgina, et al.
Publicado: (2020) -
Chimpanzee adenoviral vectors as vaccines for outbreak pathogens
por: Ewer, Katie, et al.
Publicado: (2017) -
Ebola, epidemics, and ethics - what we have learned
por: Donovan, G Kevin
Publicado: (2014) -
CMV-associated T cell and NK cell terminal differentiation does not affect immunogenicity of ChAdOx1 vaccination
por: Sharpe, Hannah R., et al.
Publicado: (2022)